FI900331A0 - Loesbar molekyl, vilken aer slaekt med en olik icam-1. - Google Patents

Loesbar molekyl, vilken aer slaekt med en olik icam-1.

Info

Publication number
FI900331A0
FI900331A0 FI900331A FI900331A FI900331A0 FI 900331 A0 FI900331 A0 FI 900331A0 FI 900331 A FI900331 A FI 900331A FI 900331 A FI900331 A FI 900331A FI 900331 A0 FI900331 A0 FI 900331A0
Authority
FI
Finland
Prior art keywords
sicam
icam
slaekt
molekyl
loesbar
Prior art date
Application number
FI900331A
Other languages
English (en)
Other versions
FI100601B (fi
Inventor
Jeffrey Greve
Alan Mcclelland
Original Assignee
Molecular Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26972210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI900331(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/301,192 external-priority patent/US5235049A/en
Application filed by Molecular Therapeutics Inc filed Critical Molecular Therapeutics Inc
Publication of FI900331A0 publication Critical patent/FI900331A0/fi
Application granted granted Critical
Publication of FI100601B publication Critical patent/FI100601B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI900331A 1989-01-24 1990-01-22 Menetelmä liukoisen intrasellulaarisen adheesiomolekyyli-1:n (sICAM-1) ja sen vasta-aineen valmistamiseksi sekä sICAM-1:tä koodaava DNA, sit ä sisältävä solu ja vasta-ainetta tuottava hybridooma FI100601B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/301,192 US5235049A (en) 1989-01-24 1989-01-24 Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
US30119289 1989-01-24
US44595189A 1989-12-13 1989-12-13
US44595189 1989-12-13

Publications (2)

Publication Number Publication Date
FI900331A0 true FI900331A0 (fi) 1990-01-22
FI100601B FI100601B (fi) 1998-01-15

Family

ID=26972210

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900331A FI100601B (fi) 1989-01-24 1990-01-22 Menetelmä liukoisen intrasellulaarisen adheesiomolekyyli-1:n (sICAM-1) ja sen vasta-aineen valmistamiseksi sekä sICAM-1:tä koodaava DNA, sit ä sisältävä solu ja vasta-ainetta tuottava hybridooma

Country Status (15)

Country Link
EP (1) EP0379904B1 (fi)
JP (1) JP3080631B2 (fi)
KR (1) KR100202435B1 (fi)
AT (1) ATE137799T1 (fi)
AU (1) AU641134B2 (fi)
DE (1) DE69026844T2 (fi)
DK (1) DK0379904T3 (fi)
ES (1) ES2087091T3 (fi)
FI (1) FI100601B (fi)
GR (1) GR3020481T3 (fi)
IE (1) IE74144B1 (fi)
IL (1) IL93119A (fi)
NO (1) NO900155L (fi)
NZ (1) NZ232203A (fi)
PT (1) PT92920B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Ag Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
DK0745852T3 (da) * 1989-03-16 2002-10-14 Blood Res Center Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
US6797270B1 (en) 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
AU710965B2 (en) * 1992-06-22 1999-09-30 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
WO1994004188A1 (en) * 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
FR2710778B1 (fr) * 1993-09-29 1995-12-01 Framatome Sa Grappe de commande pour réacteur nucléaire et réacteur en faisant application.
DE4335273A1 (de) * 1993-10-15 1995-04-20 Univ Ludwigs Albert Peptide zur Tumortherapie
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
FR2788161B1 (fr) * 1998-12-30 2001-03-23 Framatome Sa Crayon absorbant pour grappe de commande de reacteur nucleaire
AU764382B2 (en) 1999-03-19 2003-08-14 Genentech Inc. Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
WO2004074815A2 (en) * 2003-02-14 2004-09-02 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
JP4671323B2 (ja) * 2004-04-28 2011-04-13 大日本印刷株式会社 ディスプレイ装置
MXPA06014354A (es) 2004-06-09 2007-02-19 Genentech Inc Metodo para tratar granuloma anular o sarcoide.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3854536T2 (de) * 1987-05-04 1996-03-07 Dana Farber Cancer Inst Inc Interzellulare Adhäsions-Moleküle und deren Bindungsliganden.
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
CA1341055C (en) * 1987-12-08 2000-07-18 Alan Mcclelland Transfectant cell lines which express the major human rhinovirus receptor
DE68929096T2 (de) * 1988-09-01 2000-05-11 Bayer Ag Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
AU636230B2 (en) * 1990-10-24 1993-04-22 Dolores Y. Beaupied Garment to hold an ostomy appliance

Also Published As

Publication number Publication date
NZ232203A (en) 1992-10-28
JPH0381296A (ja) 1991-04-05
PT92920A (pt) 1990-07-31
AU641134B2 (en) 1993-09-16
EP0379904A1 (en) 1990-08-01
GR3020481T3 (en) 1996-10-31
DE69026844D1 (de) 1996-06-13
DK0379904T3 (da) 1996-09-16
DE69026844T2 (de) 1996-09-12
NO900155L (no) 1990-07-25
ATE137799T1 (de) 1996-05-15
IL93119A (en) 1999-07-14
JP3080631B2 (ja) 2000-08-28
AU4876790A (en) 1990-08-02
NO900155D0 (no) 1990-01-11
KR100202435B1 (ko) 1999-06-15
IL93119A0 (en) 1990-11-05
IE900257L (en) 1990-07-24
IE74144B1 (en) 1997-07-02
PT92920B (pt) 1995-12-29
FI100601B (fi) 1998-01-15
ES2087091T3 (es) 1996-07-16
EP0379904B1 (en) 1996-05-08
KR900011895A (ko) 1990-08-02

Similar Documents

Publication Publication Date Title
FI900331A0 (fi) Loesbar molekyl, vilken aer slaekt med en olik icam-1.
CA2008368A1 (en) Soluble molecule related to but distinct from icam-1
DE69330372D1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
MX9702932A (es) L-ribofuranosilnucleosidos.
ES8103976A1 (es) Un metodo de producir proteinas de interferon humano de for-ma le
ATE92326T1 (de) Adenosin-deaminase-stabile anti-retroviralnukleoside.
ATE289519T1 (de) Zusammensetzungen und verfahren zur behandlung von hepatitis c virus-bedingten erkrankungen
DE68923048T2 (de) Alpha-Subeinheit des LFA-1-Leukocyt-Adhäsions-Rezeptors.
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
GR3006073T3 (fi)
RU94043771A (ru) Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединений
MX9702926A (es) L-eritrosilnucleosidos.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE68927651T2 (de) Derivate von Fluorphosphonat-Nukleotiden
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
ES2137253T3 (es) 3-alquiloxi-, ariloxi o arilalquiloxi-benzo(b)tiofeno-2-carboxamidas utiles como inhibidoras de la adhesion celular.
DE3583400D1 (de) Zubereitungen und verfahren zum schutz von t-lymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
DE69128254T2 (de) Antihypertensive benzopyran-derivate
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2052635T3 (es) Nuevas silil alquilen aminas sustituidas.
MX9702927A (es) L-piranosilnucleosidos.
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
DE3462891D1 (en) New pyrimidine derivatives endowed with antiviral activity
BR9814575A (pt) Alcalóides monoméricos e diméricos do grupo das arilisoquinolinas e seus derivados
ES2052499T3 (es) Complejos de (gem-heterociclodimenatamina-n,n') platino.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: BAYER CORPORATION

FG Patent granted

Owner name: BAYER CORPORATION